Key Insights
The global insomnia treatment market, valued at $3.58 billion in 2025, is projected to experience robust growth, driven by a rising prevalence of sleep disorders, increased awareness among the population, and the introduction of novel therapies. The market's 5.16% CAGR from 2025 to 2033 indicates a significant expansion, fueled by factors such as an aging global population, rising stress levels associated with modern lifestyles, and increased screen time impacting sleep quality. Growth will be propelled by advancements in drug development, including non-addictive options and personalized medicine approaches, tailored to address the diverse underlying causes of insomnia. The segment comprising pharmaceutical drugs will continue to dominate, although the device segment, incorporating solutions like sleep monitoring and therapy devices, is expected to exhibit higher growth rates, driven by technological advancements and increasing patient demand for non-pharmacological interventions. Distribution channels, such as hospital pharmacies and retail pharmacies, will play crucial roles, while emerging online channels are predicted to gain traction, offering convenient access to treatments and information.
Regional variations are anticipated, with North America and Europe likely maintaining significant market shares due to high healthcare expenditure and established healthcare infrastructure. However, the Asia-Pacific region is projected to show substantial growth, driven by a rapidly expanding middle class, increasing awareness about sleep health, and rising disposable incomes allowing access to better healthcare services. Competitive landscape analysis reveals the presence of major pharmaceutical companies aggressively pursuing research and development in innovative insomnia therapies, leading to intense market competition and potentially driving prices down. The market will see a shift towards more personalized treatment plans, accounting for individual patient needs and varying responses to therapies, further driving market expansion. The increasing focus on digital therapeutics and telehealth for insomnia management will also support market growth throughout the forecast period.

Insomnia Treatment Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the Insomnia Treatment Market, offering invaluable insights for stakeholders across the pharmaceutical and healthcare sectors. Covering the period 2019-2033, with a focus on 2025, this report unveils market dynamics, competitive landscapes, and future growth prospects. The market is projected to reach xx Million by 2033, exhibiting a robust CAGR of xx% during the forecast period (2025-2033).
Insomnia Treatment Market Market Structure & Competitive Landscape
The Insomnia Treatment Market is characterized by a moderately concentrated structure, with several multinational pharmaceutical companies holding significant market share. The Herfindahl-Hirschman Index (HHI) for 2024 is estimated at xx, indicating a moderately concentrated market. Innovation plays a pivotal role, driven by the need for more effective and safer treatments. Stringent regulatory approvals, particularly from agencies like the FDA and EMA, significantly influence market entry and product lifecycle. The market also experiences competitive pressures from the availability of over-the-counter sleep aids and alternative therapies.
- Market Concentration: HHI of xx in 2024 suggests moderate concentration.
- Innovation Drivers: Development of novel drug mechanisms and improved delivery systems.
- Regulatory Impacts: Stringent approval processes influence market entry and product availability.
- Product Substitutes: Over-the-counter sleep aids and alternative therapies present competitive pressures.
- End-User Segmentation: Predominantly adult patients with chronic insomnia.
- M&A Trends: A moderate level of mergers and acquisitions (xx deals in the last 5 years) to expand product portfolios and gain market share. The total value of these M&A activities was estimated at xx Million.
Insomnia Treatment Market Market Trends & Opportunities
The Insomnia Treatment Market is experiencing significant growth, driven by rising prevalence of insomnia, increasing awareness about sleep disorders, and advancements in treatment options. The market size reached xx Million in 2024 and is projected to reach xx Million by 2033, driven by a CAGR of xx%. Technological advancements, particularly in digital therapeutics and personalized medicine, are creating new opportunities. Consumer preferences are shifting toward non-addictive and easily accessible treatments. The market is highly competitive, with both established players and emerging companies vying for market share. Market penetration of novel therapies is steadily increasing, with xx% of the market currently using newer treatments.

Dominant Markets & Segments in Insomnia Treatment Market
The North American market currently dominates the Insomnia Treatment Market, accounting for xx% of the global market share in 2024, followed by Europe with xx%. Within treatment types, prescription drugs command a significant share (xx%), with a growing demand for non-addictive options. Retail pharmacies constitute the largest distribution channel (xx%), reflecting the ease of access for consumers.
- Key Growth Drivers in North America:
- High prevalence of insomnia.
- Robust healthcare infrastructure.
- Favorable regulatory environment.
- Key Growth Drivers in Europe:
- Increasing awareness of sleep disorders.
- Growing acceptance of newer therapies.
- Expanding healthcare expenditure.
- By Treatment Type: Prescription drugs are the major segment, followed by devices. Other drugs and over the counter treatments show slower growth due to lower efficacy and side-effects
- By Distribution Channel: Retail pharmacies are major distribution channel, followed by hospital pharmacies.
Insomnia Treatment Market Product Analysis
The Insomnia Treatment Market features a diverse range of products, including prescription drugs targeting various mechanisms of insomnia, over-the-counter sleep aids, and digital therapeutics. Recent innovations focus on developing non-addictive drugs with improved efficacy and safety profiles. The market is seeing an increasing integration of technology, such as AI-powered sleep monitoring devices, improving diagnosis and personalized treatment approaches. The competitive advantage lies in developing highly efficacious drugs with reduced side effects, along with personalized digital solutions improving patient adherence.
Key Drivers, Barriers & Challenges in Insomnia Treatment Market
Key Drivers:
- Rising prevalence of insomnia globally.
- Increasing healthcare expenditure.
- Growing awareness and diagnosis of sleep disorders.
- Technological advancements in drug discovery and digital therapeutics.
Challenges & Restraints:
- High cost of novel therapies, limiting accessibility for some patients.
- Stringent regulatory approval processes.
- Potential for adverse effects associated with some treatments.
- Competition from generic and over-the-counter alternatives.
Growth Drivers in the Insomnia Treatment Market Market
The market is propelled by rising insomnia prevalence, increased healthcare spending, and advancements in treatment options, particularly non-addictive and personalized solutions. Favorable regulatory landscapes in key markets also stimulate innovation and adoption of newer therapies.
Challenges Impacting Insomnia Treatment Market Growth
High drug costs, stringent regulatory hurdles, and competition from existing and generic products constrain market growth. Supply chain disruptions and the need for improved patient adherence to treatment regimens present further challenges.
Key Players Shaping the Insomnia Treatment Market Market
- Sanofi SA
- Takeda Pharmaceutical Company Ltd
- Meda Consumer Healthcare
- Cerêve Inc
- Innovative Neurological Devices
- Pernix Therapeutics
- Eisai Co Ltd
- Ebb Therapeutics
- Electromedical Products International Inc
- Merck & Co
- Purdue Pharma LP
- Paratek Pharmaceuticals Inc
- Pfizer Inc
Significant Insomnia Treatment Market Industry Milestones
- January 2022: Idorsia received FDA approval for QUVIVIQ 25 and 50 mg for adult insomnia treatment.
- May 2022: Idorsia received European Commission marketing authorization for QUVIVIQ for adult insomnia.
- February 2024: Clinical trials initiated for Nivasorexant (ACT-539313), a selective orexin-1 receptor antagonist.
Future Outlook for Insomnia Treatment Market Market
The Insomnia Treatment Market is poised for continued growth, driven by the unmet need for effective and safe treatments. Strategic partnerships, further technological advancements, and a focus on personalized medicine will shape future market dynamics. The market expansion into emerging economies, coupled with the development of novel therapies, presents significant opportunities for market players.
Insomnia Treatment Market Segmentation
-
1. Treatment Type
-
1.1. By Drug
- 1.1.1. Benzodiazepines
- 1.1.2. Nonbenzodiazepines
- 1.1.3. Orexin Antagonist
- 1.1.4. Other Drugs
- 1.2. Devices
-
1.1. By Drug
-
2. Distribution Channel
- 2.1. Hospital Pharmacies
- 2.2. Retail Pharmacies
- 2.3. Other Distribution Channels
Insomnia Treatment Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America

Insomnia Treatment Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 5.16% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Stress Due to Highly Active Lifestyles of Individuals; Side Effects Due to Certain OTC and Prescription Medication; High Usage of Media Devices Before Sleep
- 3.3. Market Restrains
- 3.3.1. Misconceptions about the Seriousness of Insomnia; Patient Non-adherence due to Characteristic Side Effects of Insomnia Drugs
- 3.4. Market Trends
- 3.4.1. Orexin Antagonist Segment is Expected to Hold a Significant Share in the Market During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Treatment Type
- 5.1.1. By Drug
- 5.1.1.1. Benzodiazepines
- 5.1.1.2. Nonbenzodiazepines
- 5.1.1.3. Orexin Antagonist
- 5.1.1.4. Other Drugs
- 5.1.2. Devices
- 5.1.1. By Drug
- 5.2. Market Analysis, Insights and Forecast - by Distribution Channel
- 5.2.1. Hospital Pharmacies
- 5.2.2. Retail Pharmacies
- 5.2.3. Other Distribution Channels
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Middle East and Africa
- 5.3.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Treatment Type
- 6. North America Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Treatment Type
- 6.1.1. By Drug
- 6.1.1.1. Benzodiazepines
- 6.1.1.2. Nonbenzodiazepines
- 6.1.1.3. Orexin Antagonist
- 6.1.1.4. Other Drugs
- 6.1.2. Devices
- 6.1.1. By Drug
- 6.2. Market Analysis, Insights and Forecast - by Distribution Channel
- 6.2.1. Hospital Pharmacies
- 6.2.2. Retail Pharmacies
- 6.2.3. Other Distribution Channels
- 6.1. Market Analysis, Insights and Forecast - by Treatment Type
- 7. Europe Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Treatment Type
- 7.1.1. By Drug
- 7.1.1.1. Benzodiazepines
- 7.1.1.2. Nonbenzodiazepines
- 7.1.1.3. Orexin Antagonist
- 7.1.1.4. Other Drugs
- 7.1.2. Devices
- 7.1.1. By Drug
- 7.2. Market Analysis, Insights and Forecast - by Distribution Channel
- 7.2.1. Hospital Pharmacies
- 7.2.2. Retail Pharmacies
- 7.2.3. Other Distribution Channels
- 7.1. Market Analysis, Insights and Forecast - by Treatment Type
- 8. Asia Pacific Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Treatment Type
- 8.1.1. By Drug
- 8.1.1.1. Benzodiazepines
- 8.1.1.2. Nonbenzodiazepines
- 8.1.1.3. Orexin Antagonist
- 8.1.1.4. Other Drugs
- 8.1.2. Devices
- 8.1.1. By Drug
- 8.2. Market Analysis, Insights and Forecast - by Distribution Channel
- 8.2.1. Hospital Pharmacies
- 8.2.2. Retail Pharmacies
- 8.2.3. Other Distribution Channels
- 8.1. Market Analysis, Insights and Forecast - by Treatment Type
- 9. Middle East and Africa Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Treatment Type
- 9.1.1. By Drug
- 9.1.1.1. Benzodiazepines
- 9.1.1.2. Nonbenzodiazepines
- 9.1.1.3. Orexin Antagonist
- 9.1.1.4. Other Drugs
- 9.1.2. Devices
- 9.1.1. By Drug
- 9.2. Market Analysis, Insights and Forecast - by Distribution Channel
- 9.2.1. Hospital Pharmacies
- 9.2.2. Retail Pharmacies
- 9.2.3. Other Distribution Channels
- 9.1. Market Analysis, Insights and Forecast - by Treatment Type
- 10. South America Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Treatment Type
- 10.1.1. By Drug
- 10.1.1.1. Benzodiazepines
- 10.1.1.2. Nonbenzodiazepines
- 10.1.1.3. Orexin Antagonist
- 10.1.1.4. Other Drugs
- 10.1.2. Devices
- 10.1.1. By Drug
- 10.2. Market Analysis, Insights and Forecast - by Distribution Channel
- 10.2.1. Hospital Pharmacies
- 10.2.2. Retail Pharmacies
- 10.2.3. Other Distribution Channels
- 10.1. Market Analysis, Insights and Forecast - by Treatment Type
- 11. North America Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
- 12. Europe Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 Germany
- 12.1.2 United Kingdom
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Rest of Europe
- 13. Asia Pacific Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 India
- 13.1.4 Australia
- 13.1.5 South Korea
- 13.1.6 Rest of Asia Pacific
- 14. Middle East and Africa Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 GCC
- 14.1.2 South Africa
- 14.1.3 Rest of Middle East and Africa
- 15. South America Insomnia Treatment Market Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Rest of South America
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 Sanofi SA
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Takeda Pharmaceutical Company Ltd
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Meda Consumer Healthcare
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Cerêve Inc
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Innovative Neurological Devices
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Pernix Therapeutics
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Eisai Co Ltd
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Ebb Therapeutics
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 Electromedical Products International Inc
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Merck & Co
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 Purdue Pharma LP
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.12 Paratek Pharmaceuticals Inc
- 16.2.12.1. Overview
- 16.2.12.2. Products
- 16.2.12.3. SWOT Analysis
- 16.2.12.4. Recent Developments
- 16.2.12.5. Financials (Based on Availability)
- 16.2.13 Pfizer Inc
- 16.2.13.1. Overview
- 16.2.13.2. Products
- 16.2.13.3. SWOT Analysis
- 16.2.13.4. Recent Developments
- 16.2.13.5. Financials (Based on Availability)
- 16.2.1 Sanofi SA
List of Figures
- Figure 1: Global Insomnia Treatment Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Insomnia Treatment Market Volume Breakdown (K Unit, %) by Region 2024 & 2032
- Figure 3: North America Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 4: North America Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 5: North America Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 6: North America Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 7: Europe Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 8: Europe Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 9: Europe Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: Europe Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 11: Asia Pacific Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 12: Asia Pacific Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 13: Asia Pacific Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 14: Asia Pacific Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 15: Middle East and Africa Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 16: Middle East and Africa Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 17: Middle East and Africa Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: Middle East and Africa Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 19: South America Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 20: South America Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 21: South America Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 22: South America Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 23: North America Insomnia Treatment Market Revenue (Million), by Treatment Type 2024 & 2032
- Figure 24: North America Insomnia Treatment Market Volume (K Unit), by Treatment Type 2024 & 2032
- Figure 25: North America Insomnia Treatment Market Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 26: North America Insomnia Treatment Market Volume Share (%), by Treatment Type 2024 & 2032
- Figure 27: North America Insomnia Treatment Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 28: North America Insomnia Treatment Market Volume (K Unit), by Distribution Channel 2024 & 2032
- Figure 29: North America Insomnia Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 30: North America Insomnia Treatment Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 31: North America Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 32: North America Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 33: North America Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 34: North America Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 35: Europe Insomnia Treatment Market Revenue (Million), by Treatment Type 2024 & 2032
- Figure 36: Europe Insomnia Treatment Market Volume (K Unit), by Treatment Type 2024 & 2032
- Figure 37: Europe Insomnia Treatment Market Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 38: Europe Insomnia Treatment Market Volume Share (%), by Treatment Type 2024 & 2032
- Figure 39: Europe Insomnia Treatment Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 40: Europe Insomnia Treatment Market Volume (K Unit), by Distribution Channel 2024 & 2032
- Figure 41: Europe Insomnia Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 42: Europe Insomnia Treatment Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 43: Europe Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 44: Europe Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 45: Europe Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 46: Europe Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 47: Asia Pacific Insomnia Treatment Market Revenue (Million), by Treatment Type 2024 & 2032
- Figure 48: Asia Pacific Insomnia Treatment Market Volume (K Unit), by Treatment Type 2024 & 2032
- Figure 49: Asia Pacific Insomnia Treatment Market Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 50: Asia Pacific Insomnia Treatment Market Volume Share (%), by Treatment Type 2024 & 2032
- Figure 51: Asia Pacific Insomnia Treatment Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 52: Asia Pacific Insomnia Treatment Market Volume (K Unit), by Distribution Channel 2024 & 2032
- Figure 53: Asia Pacific Insomnia Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 54: Asia Pacific Insomnia Treatment Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 55: Asia Pacific Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 56: Asia Pacific Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 57: Asia Pacific Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 58: Asia Pacific Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 59: Middle East and Africa Insomnia Treatment Market Revenue (Million), by Treatment Type 2024 & 2032
- Figure 60: Middle East and Africa Insomnia Treatment Market Volume (K Unit), by Treatment Type 2024 & 2032
- Figure 61: Middle East and Africa Insomnia Treatment Market Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 62: Middle East and Africa Insomnia Treatment Market Volume Share (%), by Treatment Type 2024 & 2032
- Figure 63: Middle East and Africa Insomnia Treatment Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 64: Middle East and Africa Insomnia Treatment Market Volume (K Unit), by Distribution Channel 2024 & 2032
- Figure 65: Middle East and Africa Insomnia Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 66: Middle East and Africa Insomnia Treatment Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 67: Middle East and Africa Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 68: Middle East and Africa Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 69: Middle East and Africa Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 70: Middle East and Africa Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
- Figure 71: South America Insomnia Treatment Market Revenue (Million), by Treatment Type 2024 & 2032
- Figure 72: South America Insomnia Treatment Market Volume (K Unit), by Treatment Type 2024 & 2032
- Figure 73: South America Insomnia Treatment Market Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 74: South America Insomnia Treatment Market Volume Share (%), by Treatment Type 2024 & 2032
- Figure 75: South America Insomnia Treatment Market Revenue (Million), by Distribution Channel 2024 & 2032
- Figure 76: South America Insomnia Treatment Market Volume (K Unit), by Distribution Channel 2024 & 2032
- Figure 77: South America Insomnia Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 78: South America Insomnia Treatment Market Volume Share (%), by Distribution Channel 2024 & 2032
- Figure 79: South America Insomnia Treatment Market Revenue (Million), by Country 2024 & 2032
- Figure 80: South America Insomnia Treatment Market Volume (K Unit), by Country 2024 & 2032
- Figure 81: South America Insomnia Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 82: South America Insomnia Treatment Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Insomnia Treatment Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Insomnia Treatment Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: Global Insomnia Treatment Market Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 4: Global Insomnia Treatment Market Volume K Unit Forecast, by Treatment Type 2019 & 2032
- Table 5: Global Insomnia Treatment Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 6: Global Insomnia Treatment Market Volume K Unit Forecast, by Distribution Channel 2019 & 2032
- Table 7: Global Insomnia Treatment Market Revenue Million Forecast, by Region 2019 & 2032
- Table 8: Global Insomnia Treatment Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 9: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 10: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 11: United States Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: United States Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 13: Canada Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Canada Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: Mexico Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Mexico Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 17: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 19: Germany Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Germany Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 21: United Kingdom Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: United Kingdom Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 23: France Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: France Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 25: Italy Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Italy Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 27: Spain Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Spain Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 29: Rest of Europe Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Rest of Europe Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 31: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 32: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 33: China Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: China Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 35: Japan Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: Japan Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 37: India Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: India Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 39: Australia Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: Australia Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 41: South Korea Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: South Korea Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 43: Rest of Asia Pacific Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Rest of Asia Pacific Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 45: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 46: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 47: GCC Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: GCC Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 49: South Africa Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: South Africa Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 51: Rest of Middle East and Africa Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 52: Rest of Middle East and Africa Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 53: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 54: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 55: Brazil Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Brazil Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 57: Argentina Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: Argentina Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 59: Rest of South America Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 60: Rest of South America Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 61: Global Insomnia Treatment Market Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 62: Global Insomnia Treatment Market Volume K Unit Forecast, by Treatment Type 2019 & 2032
- Table 63: Global Insomnia Treatment Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 64: Global Insomnia Treatment Market Volume K Unit Forecast, by Distribution Channel 2019 & 2032
- Table 65: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 66: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 67: United States Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 68: United States Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 69: Canada Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 70: Canada Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 71: Mexico Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 72: Mexico Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 73: Global Insomnia Treatment Market Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 74: Global Insomnia Treatment Market Volume K Unit Forecast, by Treatment Type 2019 & 2032
- Table 75: Global Insomnia Treatment Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 76: Global Insomnia Treatment Market Volume K Unit Forecast, by Distribution Channel 2019 & 2032
- Table 77: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 78: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 79: Germany Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 80: Germany Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 81: United Kingdom Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 82: United Kingdom Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 83: France Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 84: France Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 85: Italy Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 86: Italy Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 87: Spain Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 88: Spain Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 89: Rest of Europe Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 90: Rest of Europe Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 91: Global Insomnia Treatment Market Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 92: Global Insomnia Treatment Market Volume K Unit Forecast, by Treatment Type 2019 & 2032
- Table 93: Global Insomnia Treatment Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 94: Global Insomnia Treatment Market Volume K Unit Forecast, by Distribution Channel 2019 & 2032
- Table 95: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 96: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 97: China Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 98: China Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 99: Japan Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 100: Japan Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 101: India Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 102: India Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 103: Australia Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 104: Australia Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 105: South Korea Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 106: South Korea Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 107: Rest of Asia Pacific Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 108: Rest of Asia Pacific Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 109: Global Insomnia Treatment Market Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 110: Global Insomnia Treatment Market Volume K Unit Forecast, by Treatment Type 2019 & 2032
- Table 111: Global Insomnia Treatment Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 112: Global Insomnia Treatment Market Volume K Unit Forecast, by Distribution Channel 2019 & 2032
- Table 113: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 114: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 115: GCC Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 116: GCC Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 117: South Africa Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 118: South Africa Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 119: Rest of Middle East and Africa Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 120: Rest of Middle East and Africa Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 121: Global Insomnia Treatment Market Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 122: Global Insomnia Treatment Market Volume K Unit Forecast, by Treatment Type 2019 & 2032
- Table 123: Global Insomnia Treatment Market Revenue Million Forecast, by Distribution Channel 2019 & 2032
- Table 124: Global Insomnia Treatment Market Volume K Unit Forecast, by Distribution Channel 2019 & 2032
- Table 125: Global Insomnia Treatment Market Revenue Million Forecast, by Country 2019 & 2032
- Table 126: Global Insomnia Treatment Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 127: Brazil Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 128: Brazil Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 129: Argentina Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 130: Argentina Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 131: Rest of South America Insomnia Treatment Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 132: Rest of South America Insomnia Treatment Market Volume (K Unit) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Insomnia Treatment Market?
The projected CAGR is approximately 5.16%.
2. Which companies are prominent players in the Insomnia Treatment Market?
Key companies in the market include Sanofi SA, Takeda Pharmaceutical Company Ltd, Meda Consumer Healthcare, Cerêve Inc, Innovative Neurological Devices, Pernix Therapeutics, Eisai Co Ltd, Ebb Therapeutics, Electromedical Products International Inc, Merck & Co, Purdue Pharma LP, Paratek Pharmaceuticals Inc, Pfizer Inc.
3. What are the main segments of the Insomnia Treatment Market?
The market segments include Treatment Type, Distribution Channel.
4. Can you provide details about the market size?
The market size is estimated to be USD 3.58 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Stress Due to Highly Active Lifestyles of Individuals; Side Effects Due to Certain OTC and Prescription Medication; High Usage of Media Devices Before Sleep.
6. What are the notable trends driving market growth?
Orexin Antagonist Segment is Expected to Hold a Significant Share in the Market During the Forecast Period.
7. Are there any restraints impacting market growth?
Misconceptions about the Seriousness of Insomnia; Patient Non-adherence due to Characteristic Side Effects of Insomnia Drugs.
8. Can you provide examples of recent developments in the market?
February 2024: Nivasorexant (ACT-539313), the first selective orexin-1 receptor antagonist (SO1RA), was investigated during clinical trials.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Insomnia Treatment Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Insomnia Treatment Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Insomnia Treatment Market?
To stay informed about further developments, trends, and reports in the Insomnia Treatment Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence